Asahina Y, Enomoto N, Ogura Y, Kurosaki M, Sakuma I, Izumi N, Marumo F, Sato C
Second Department of Internal Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
J Hepatol. 1996 Dec;25(6):787-94. doi: 10.1016/s0168-8278(96)80280-7.
BACKGROUND/AIM: During the course of persistent hepatitis B virus infection, viral replication markedly decreases after acute exacerbation of liver inflammation accompanied by emergence of antihepatitis B e antibody (anti-HBe) and/or anti-hepatitis B surface antibody (anti-HBs). In some cases, however, persistent viral replication continues even after such exacerbation with or without HBeAg/anti-HBe seroconversion. The aim of the present study was to investigate the extent of genetic variations of HBV in this phenomenon.
Full-length HBV genomes were amplified by polymerase chain reaction from sera of three patients before and after acute exacerbation and were directly sequenced.
In the whole genomes of 3215 nucleotides, only six nucleotide mutations for six amino acid substitutions (2 in the surface gene, 2 in the X gene, 1 in the core gene and 1 in the polymerase gene) were observed in patient 1, 15 mutations for 14 amino acid substitutions (1 in the pre-core codon 28, 4 in the surface gene, 4 in the core gene and 5 in the polymerase gene) were observed in patient 2, and 5 mutations for 6 amino acid substitutions (2 in the surface gene, 2 in the X gene, pre-core stop codon mutation and 1 in the polymerase gene) were observed in patient 3. Substitution in the a determinant of the surface gene, which encodes target epitopes for neutralizing antibodies, as well as those in the pre-core/core gene, which encodes epitopes for cytotoxic T cells, were mainly found.
HBV that remained after the emergence of anti-HBe and anti-HBs are considered to possess mutations in epitopes for both humoral and cellular immunity. These mutant HBV may be involved in the pathogenesis of persistent hepatic injury after acute exacerbation.
背景/目的:在慢性乙型肝炎病毒感染过程中,肝脏炎症急性加重并伴有抗乙型肝炎e抗体(抗-HBe)和/或抗乙型肝炎表面抗体(抗-HBs)出现后,病毒复制显著减少。然而,在某些情况下,即使在这种加重之后,无论有无HBeAg/抗-HBe血清学转换,病毒仍持续复制。本研究的目的是调查这一现象中HBV基因变异的程度。
通过聚合酶链反应从三名患者急性加重前后的血清中扩增全长HBV基因组,并直接进行测序。
在3215个核苷酸的全基因组中,患者1仅观察到6个核苷酸突变导致6个氨基酸替换(表面基因2个,X基因2个,核心基因1个,聚合酶基因1个),患者2观察到15个突变导致14个氨基酸替换(前核心密码子28位1个,表面基因4个,核心基因4个,聚合酶基因5个),患者3观察到5个突变导致6个氨基酸替换(表面基因2个,X基因2个,前核心终止密码子突变,聚合酶基因1个)。主要发现了编码中和抗体靶表位的表面基因a决定簇以及编码细胞毒性T细胞表位的前核心/核心基因中的替换。
抗-HBe和抗-HBs出现后仍存在的HBV被认为在体液免疫和细胞免疫表位中都存在突变。这些突变的HBV可能参与急性加重后持续性肝损伤的发病机制。